Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dihydrolipoic acid is the reduced form of lipoic acid and is a naturally occurring dithiol compound. It features two thiol groups and acts as a potent antioxidant, directly scavenging reactive oxygen species such as superoxide, hydroperoxy, and hydroxyl radicals. Dihydrolipoic acid plays an important role in cellular metabolism by participating in redox reactions within mitochondria and serving as a cofactor for enzyme complexes involved in energy production (notably the pyruvate dehydrogenase complex). The R-enantiomer is biochemically significant. Dihydrolipoic acid has demonstrated neuroprotective and anti-tumor effects in experimental settings but is primarily used as a research chemical or dietary supplement rather than an approved pharmaceutical drug[1][3][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dihydrolipoic acid.